Adage Capital Partners Gp, L.L.C. Frequency Therapeutics, Inc. Transaction History

Adage Capital Partners Gp, L.L.C.

  • $54.6 Billion
  • Q3 2024

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023
BUY
$0.35 - $0.72 $420,000 - $864,000
1,200,000 New
1,200,000 $444,000

About Frequency Therapeutics, Inc.

FREQ Quotes by TradingView
  • Ticker FREQ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 35,262,000
  • Description
  • Frequency Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapeutics to activate a person's innate regenerative potential to restore function. Its Progenitor Cell Activation approach uses small molecules and activate progenitor cells within the body to create functional tissue. The company's lead product candi...
More about FREQ
Track This Portfolio

Track Adage Capital Partners Gp, L.L.C. Portfolio

Follow Adage Capital Partners Gp, L.L.C. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Adage Capital Partners Gp, L.L.C., based on Form 13F filings with the SEC.

News

Stay updated on Adage Capital Partners Gp, L.L.C. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email